Alphatec Holdings Inc

ATEC remains in a Stage 2 consolidation following the mid-July Bullish Pivot Point that signaled structural repair and upside mean reversion. Medium-term directional bias is bullish, but short-term execution is neutral as price tightly tracks flat 9/20 EMAs within a narrow range. Execution is deferred (Stalk) until a pullback into EMA support or a decisive breakout above the congestion zone. The longer-term downtrend below the 200 DMA persists, warranting caution.

• ↑Q2 revenue of $214M (+15% YoY), surgical revenue $196M (+17%).
• ↑Surgical cases +20% and new surgeon adoption +24% drive growth.
• ↓Profitability score negative; EPS misses indicate shaky profit model.